← Back to Search

Group Psychotherapy for Mild Cognitive Impairment (MIND-MCI Trial)

N/A
Recruiting
Led By Patricia Pilkinton, MD
Research Sponsored by Tuscaloosa Research & Education Advancement Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
diagnosis of at least one cardiovascular risk factor (i.e., hypertension, diabetes mellitus II, hyperlipidemia/hypercholesterolemia, or obesity)
age 60 or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at week 10 (one week after completion of the 9 video-telehealth sessions)
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if a 9-week video therapy group helps veterans with MCI improve their well-being and quality-of-life.

Who is the study for?
This trial is for English-speaking veterans aged 60 or older with Mild Cognitive Impairment (MCI) diagnosed at least a month prior. Participants must have one cardiovascular risk factor like hypertension, diabetes type II, high cholesterol, or obesity and feel their memory/thinking issues impact their life.
What is being tested?
The study tests if a 9-week group psychotherapy via video telehealth can improve the well-being and quality of life for veterans with MCI. It compares immediate participation in therapy to a delayed start, using questionnaires before and after sessions to measure outcomes.
What are the potential side effects?
Since this intervention involves group psychotherapy without medications, typical medical side effects are not expected. However, participants may experience emotional discomfort discussing personal issues during therapy.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with a condition like high blood pressure, type 2 diabetes, high cholesterol, or obesity.
Select...
I am 60 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at week 10 (one week after completion of the 9 video-telehealth sessions)
This trial's timeline: 3 weeks for screening, Varies for treatment, and at week 10 (one week after completion of the 9 video-telehealth sessions) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability of a group video-telehealth intervention for veterans with MCI
Feasibility of a group video-telehealth intervention for veterans with MCI
Secondary study objectives
Change in the Quality of Life in Alzheimers Disease (QOL-AD, range of 13-52) scale in Veterans with Mild Cognitive Impairment following participation in a 9-week video-telehealth intervention.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Group therapy delivered via video telehealth - wait list controlExperimental Treatment1 Intervention
Nine sessions of 60 min each group therapy delivered via telehealth after a waiting period.
Group II: Group therapy delivered via video telehealthExperimental Treatment1 Intervention
Nine sessions of 60 min each group therapy delivered via telehealth

Find a Location

Who is running the clinical trial?

Tuscaloosa Research & Education Advancement CorporationLead Sponsor
14 Previous Clinical Trials
2,187 Total Patients Enrolled
1 Trials studying Dementia
20 Patients Enrolled for Dementia
United States Department of DefenseFED
917 Previous Clinical Trials
334,581 Total Patients Enrolled
5 Trials studying Dementia
1,449 Patients Enrolled for Dementia
Patricia Pilkinton, MDPrincipal InvestigatorTuscaloosa Veterans Affairs Medical Center
Lindsay Jacobs, PhDPrincipal InvestigatorTuscaloosa Veterans Affairs Medical Center
~53 spots leftby Jul 2025